Clinical Trial Details
EORTC-20931-LYMG
Back to Clinical Trials Database
Protocol H8 for a prospective controlled trial in stage I-II supradiaphragmatic Hodgkin's disease. Evaluation of treatment efficacy and (long term) toxicity in three different prognostic subgroups. H8 Trial
| Trial Status | LT-FU ongoing |
|---|---|
| Dates |
Date of activation: 15-Sep-1993 Date Step1 close: 15-Oct-1998 |
| Data management at EORTC | Yes |
| Design |
Phase 3 Randomized open label |
| Targeted Sample size | All Groups: 1333 |
| Treatment |
Radiotherapy, Drug |
| Study Staff | Laurens Vinckier (Pharmacovigilance Manager) , EORTC Headquarters, Brussels |
| Type of cancer | Hodgkins Disease |
| Participating groups | EORTC Lymphoma Group |
| Protocol summary | http://clinicaltrials.gov/study/NCT00379041 |
| NCT number | NCT00379041 |
| Financial Support | Academic Fund |
